xCures raises $46 million to organize patient data

What happened

xCures, which uses AI to structure patient medical records, raised $46 million（約74億円） in a Series B round led by Innovius Capital. The funding brings total capital to more than $76 million（約120億円） since 2018 and values the company at $127 million（約200億円） post-money—more than double its previous Series A valuation of $127 million（約200億円） from December 2023.

Why it matters

Healthcare organizations spend vast sums managing scattered, messy patient data across thousands of hospitals and labs. xCures' technology converts unstructured records into structured, decision-ready information—a task the company's CEO estimates puts it three to five years ahead of competitors. The company has processed more than 300 million medical records from more than 550,000 healthcare locations and supports clinical decisions for millions of patients.

What to watch

xCures grew annualized recurring revenue from roughly $3 million（約4.8億円） to $10 million（約16億円） in 2025 and expects to reach $20 million（約32億円） by 2026. The 25-member enterprise customer base includes lab diagnostics firms (Exact Sciences, Caris Life Sciences, Novocure) and large hospital networks using the tool for operating-room scheduling, risk stratification, and administrative automation.